Testimony on Comparative Effectiveness Research

Nancy H. Covell, New York State Psychiatric Institute

On April 3, 2009, public testimony on comparative effectiveness research was given at a meeting of the National Advisory Council for Healthcare Research and Quality. The testimony represents the views of the presenter and not necessarily those of the Agency for Healthcare Research and Quality (AHRQ) or the Department of Health and Human Services (HHS).

Delivered Via Electronic Mail

Dear Persons-

I am writing to note the need for comparative effectiveness studies targeting antipsychotic polypharmacy. This practice places enormous burden on state and other provider budgets while also exposing individuals to increased risk of side effects, yet there is little data to guide it's effectiveness compared to other alternatives. I am happy to see dollars set aside for such important research and look forward to reading the minutes from your public meeting.

Sincerely yours,

Nancy H. Covell, Ph.D.
Research Project Director I
Department of Mental Health Services and Policy Research
New York State Psychiatric Institute

Associate Director of Research
CT DMHAS Research Division
410 Capitol Avenue, MS#14RSD
PO Box 341431
Hartford, CT 06134
USA

Current as of April 2009
Internet Citation: Testimony on Comparative Effectiveness Research: Nancy H. Covell, New York State Psychiatric Institute. April 2009. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/news/newsroom/speech/covell.html